Mainz Biomed Secures Additional $1.5M Funding

Mainz Biomed B.V. (MYNZ) has released an update.

Mainz Biomed B.V. has entered into a supplemental agreement with YA II PN, LTD. for a fourth Pre-Paid Advance of $1.5 million, following three previous promissory notes totaling $14.3 million. The funds from this latest note are designated for working capital and general corporate purposes, ensuring the company’s continued operations without shareholder approval for issuance. The transaction is exempt from registration under the Securities Act, indicating a private placement strategy.

For further insights into MYNZ stock, check out TipRanks’ Stock Analysis page.